Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens | MicrobiomeTrials← Back to trialsNCT04821141
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-12-14Est. Completion: 2026-10
Enrollment target: 120 participants Locations- City of Hope Medical Center, Duarte, California, United States
- University of California San Francisco, San Francisco, California, United States
- Northwestern Medical Center, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Traumatic Brain InjuryIntracranial Hemorrhages
Elderly patients on direct oral anticoagulants (DOACs), specifically factor Xa (FXa) inhibitors such as apixaban and riv…
Ljubljana, SloveniaCompleted Aug 1, 2026
IntubationCardiovascular Surgical Procedure
The iCAN trial is a pragmatic randomized controlled trial that aims to test the hypothesis that HFNC versus usual care o…
Nashville, United StatesCompleted Nov 19, 2025
Completed
The investigator hypothesizes that the combined use of
1. non-invasive biomarkers including dd-cfDNA in peripheral bloo…
Nantes, FranceCompleted May 28, 2024